ICT expenditure, which grew by almost 20% was also affected by this consumer shift. This exemplifies that more and more people have begun to adopt digital technology as part of their lives, including the means by which they attain healthcare services.

Amidst the pandemic, a sustainable, self-reliant health industry within Indonesia became a rising concern. Biotech startup, Nusantics, showcased the ability of Indonesian scientists to design and produce a home grown prototype for PCR test kits in partnership with state-owned Bio Farma as part of the Indonesia PASTI BISA initiative.

Nalagenetics is a biotechnology startup that focuses on precision medicine and building hospital capabilities in handling processes such as planning, building, and operating Bio Safety Labs. This helps hospitals in Indonesia to increase their COVID-19 testing capacity and also build other pharmacogenomic testing capabilities.

“As more funds are allocated to healthcare and public awareness of healthy living increases, digital healthcare will now become a significant contributor to GDP.”

CEO and Co-founder
Jonathan Sudartha

Jonathan Sudartha, CEO and Co-Founder of Halodoc, believes in the potential for healthcare to become a driver of Indonesia’s GDP. Jonathan, who received his bachelor’s degree in e-commerce from Curtin University, Australia, has more than 15 years of experience as a professional in the pharmaceutical industry, including with the Mensa Group.

Download The EV-DCI 2021 Report